Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. - Wikidata - wikimedia - TriplyDB

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

http://www.wikidata.org/entity/Q34308238

about

Recent progress in histochemistry and cell biology.D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.Systemic and renal lipids in kidney disease development and progression.ApoE deficiency promotes colon inflammation and enhances inflammatory potential oxidized-LDL and TNF-α in colon epithelial cells.Signaling pathways of apoE and its role of gene expression in glomerulus diseases.Role of apolipoprotein E in renal damage protection.

P2860

Q34172616-DFA1D5BB-6BE0-4500-A4DD-5FED6104239E Q35642491-29B414F4-D6C0-482D-8C42-20288EEA7F82 Q37148885-C62F0407-EE2D-405E-AF04-815032264BA6 Q37315219-ECBB64EE-E639-46B1-A2F3-D2345E05337C Q38079285-11E09708-BB2C-4690-8342-4C94E5CFBFEF Q45083057-4C0E69BC-6F5A-4F10-B42D-15ED03A316F2

P2860

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

http://www.wikidata.org/entity/Q34308238

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@ast

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@en

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@nl

type

label

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@ast

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@en

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@nl

prefLabel

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@ast

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@en

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@nl

P1433

Q34308238-E5CB6F87-D1EA-4230-B231-E2CC5263FEF7

P1476

Q34308238-B3A8BCAE-9F19-4C41-A4FF-7CF640270EF4

P2093

Q34308238-00B1AAA4-D3FA-462B-8FB6-7856CB0C1FB0

Q34308238-1E1601CF-C880-4F73-BC75-1035CA10CA7C

Q34308238-249B3C16-3FE6-46AF-B226-B76A705E5A42

Q34308238-554BF9B0-F248-4534-BD57-8D2B86613B0C

Q34308238-57CAE104-E95F-441F-9E34-5E0FA5913C1B

Q34308238-5D30FC87-9F17-4030-9D4B-46A6FADC0BE5

Q34308238-D88A5A49-90A3-45F0-9346-8CB5B22125FC

Q34308238-E82A8866-BF4B-48AD-BF24-CE16618F6DF2

Q34308238-E906B25C-1242-4DA5-B95F-021B56017AA9

Q34308238-FECEAEAD-6466-4EED-BBCF-B91F70CAF72A

P2860

Q34308238-00788995-F381-4CE5-A76B-97310893D975

Q34308238-0AF24478-6525-4EEB-982D-768DA541675D

Q34308238-178D8B2A-E920-4221-A026-B4E0E22E7AE5

Q34308238-197E72D6-276A-41CA-A4F7-17456F331AD0

Q34308238-22E577CD-298F-443B-BF54-E406AFCD02BC

Q34308238-2867089B-B3C3-4DD9-8475-9E4C9AD37723

Q34308238-2F3FB3C5-FFD2-40F7-81C6-C7B48E29E62E

Q34308238-3CF5ED5C-A36D-40B0-BFFF-F2E236315D72

Q34308238-4775EB6C-8426-41BF-B7C2-0ACB0A412CD9

Q34308238-5213E741-C5FB-4CBB-8086-EE53FF25AAA9

P304

Q34308238-5E3AC9B2-FCB6-4A00-8BB3-DDE18A1549FB

P31

Q34308238-1354B322-461C-4FDB-97C1-BF866B7B9CCB

P356

Q34308238-994D50F2-A76A-4A3C-BBAE-BAFD120C5BE8

P407

Q34308238-0432EC94-B26F-435D-A109-2C82AAED0820

P433

Q34308238-3824BF14-B901-42C2-ABC3-8EFAC734C87E

P478

Q34308238-98576DB6-424B-4629-BE23-A7AAE0B5CCE8

P577

Q34308238-379687B6-3155-4A1A-84EE-F812F7CAD97C

P5875

Q34308238-89DE104F-671C-47C1-9004-18C757FF0D77

P698

Q34308238-9C62B26E-DF3A-4CCD-AECB-C4A2A76F8B43

P932

Q34308238-5CFFB601-2AAC-4494-B77C-0B6FEF4AA4BE

P356

P1433

Nephrology Dialysis Transplantation

P1476

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

@en

P2093

Alan M Fogelman

http://www.w3.org/2001/XMLSchema#string

Bernardo Rodriguez-Iturbe

http://www.w3.org/2001/XMLSchema#string

Farbod Farmand

http://www.w3.org/2001/XMLSchema#string

Hamid Moradi

http://www.w3.org/2001/XMLSchema#string

Hyun Ju Kim

http://www.w3.org/2001/XMLSchema#string

Kaveh Navab

http://www.w3.org/2001/XMLSchema#string

Mohamad Navab

http://www.w3.org/2001/XMLSchema#string

Nosratola D Vaziri

http://www.w3.org/2001/XMLSchema#string

Susan Hama

http://www.w3.org/2001/XMLSchema#string

Yasmir Quiroz

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: far more than a lipid transport protein

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease.

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

The role of lipids in renal disease: future challenges.

Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.

Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications.

In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.

Are suppressors of cytokine signaling proteins recently identified in atherosclerosis possible therapeutic targets?

P304

3525-3534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFQ274

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44617376

http://www.w3.org/2001/XMLSchema#string

P698

20488818

http://www.w3.org/2001/XMLSchema#string

P932

2980997

http://www.w3.org/2001/XMLSchema#string